Form 4: Braden Michael Leonard Reports Beneficial Ownership Changes in OnKure Therapeutics Following Merger

Braden Michael Leonard, a former 10% owner of RPHM, reports changes in beneficial ownership of OnKure Therapeutics stock following the merger with Reneo Pharmaceuticals.

Summary

• Braden Michael Leonard filed a Form 4 detailing changes in his beneficial ownership of OnKure Therapeutics, Inc. (OKUR) stock.
• The changes result from the merger between Reneo Pharmaceuticals and OnKure, which closed on October 4, 2024.
• As part of the merger, Reneo executed a 1-for-10 reverse stock split.
• Leonard received 345,739 shares indirectly through BML Investment Partners, L.P., where BML Capital Management, LLC serves as the general partner and Leonard is the managing member.
• He also received 102,076 shares directly.
• Leonard disclaims beneficial ownership of the shares held by BML Investment Partners, L.P., except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports changes in ownership.

Industry Context

Form 4 filings are standard practice when insiders or significant shareholders experience a change in their ownership of a company's stock, particularly following major corporate events like mergers. This filing provides transparency to the market regarding the holdings of key individuals.

Stakeholder Impact

• Shareholders are informed about the changes in beneficial ownership following the merger.
• The filing provides transparency regarding the holdings of a significant shareholder.

Key Dates